Antony I, Asmar R, Carette B, Démolis P, Vaïsse B
Service de physiologie et d'explorations fonctionnelles, hôpital Louis-Mourier, Colombes.
Arch Mal Coeur Vaiss. 2001 Aug;94(8):897-900.
The REVEIL study is a pilot studies to determine the feasibility of self blood pressure measurement (SBPM). Feasibility was assessed by the quality of measurements and the patient opinion. This preliminary report focused on the patient opinion. Patients were included in the study by their general practitioner or cardiologist when he thought there was an indication for SBPM. Patients were excluded if their physical or mental autonomy was not sufficient to perform SBPM or if they were arrhythmic. The lending of the device was free (against a guarantee of 800 F) and it was available in one of the 44 drugstores that participated to the study. The physician performed patient education about SBPM and the druggist explained the handling of the device. SBPM was performed over a 7-day period: every day two series of 3 consecutive measurements were requested in the morning before taking the antihypertensive treatment, and in the evening between dinner and bedtime. The device was the validated OMRON 705 CP. 428 patients were included in the study. Among them, 385 (90%) accepted to participate to the study and 43 refused (10%). Almost half of the refusals were due to patients that did not want to take care of them and 16% were justified by a technical problem. Preliminary data included 362 patients aged 55.2 years, 79 of them older than 70 years. 80 patients (22%) experienced difficulties to perform SBPM, 28 of them (7.3%) to perform measurements and 13 (3.4%) to understand how worked the device. At the end of the study, 82 patients (23%) had better understanding of their hypertension, 90 patients (25%) felt themselves more motivated to take their medication and 111 patients (31%) found that their physician took better charge of them. 286 patients (79%) evaluated the overall satisfaction at SBPM. Among them, 276 patients (97%) were very satisfied (57%) or satisfied (40%) with SBPM when only 3% of patients were not. In summary, SBPM was easily performed in the conditions of the REVEIL study, and the majority of patients was satisfied with this experience.
REVEIL研究是一项旨在确定自我血压测量（SBPM）可行性的试点研究。通过测量质量和患者意见来评估可行性。本初步报告聚焦于患者意见。当全科医生或心脏病专家认为有自我血压测量的指征时，患者被纳入研究。如果患者的身体或精神自主能力不足以进行自我血压测量，或者患有心律失常，则被排除在外。设备出借免费（需800法郎押金），可在参与研究的44家药店中的一家获取。医生对患者进行自我血压测量方面的教育，药剂师讲解设备的使用方法。自我血压测量持续7天：每天在早晨服用降压药之前和晚上晚餐至就寝时间之间，各进行两组，每组连续测量3次。所用设备为经过验证的欧姆龙705 CP。428名患者被纳入研究。其中，385名（90%）同意参与研究，43名（10%）拒绝。几乎一半的拒绝是因为患者不想照看设备，16%的拒绝是由于技术问题。初步数据包括362名年龄为55.2岁的患者，其中79名年龄超过70岁。80名患者（22%）在进行自我血压测量时遇到困难，其中28名（7.3%）在测量方面有困难，13名（3.4%）在理解设备工作原理方面有困难。在研究结束时，82名患者（23%）对自己的高血压有了更好的了解，90名患者（25%）感觉自己服药的积极性更高，111名患者（31%）发现医生对他们的治疗更上心。286名患者（79%）对自我血压测量的总体满意度进行了评估。其中，276名患者（97%）对自我血压测量非常满意（57%）或满意（40%），只有3%的患者不满意。总之，在REVEIL研究的条件下，自我血压测量易于进行，大多数患者对这一体验感到满意。
